USPTO 2015–2025 USPTO PatentsView US Corporation

Axogen Corporation

USPTO PatentsView assignee record - 39 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

21.4

Avg claims per patent

+243%

5-year grant velocity

The verdict

According to USPTO PatentsView, Axogen ranks #8,165 of 50,000 tracked US assignees by granted-patent volume, with 39 patents across 14 technology areas.

#8,165
of 50,000 US assignees by volume: Top 22%
by Innovation Score (46.0/100): 21.4
avg claims per patent: +243%
grant velocity, last 5 yrs

Portfolio overview

Axogen Corporation has been granted 39 US utility patents between 2017 and 2025, placing Axogen Corporation at #8,165 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Axogen Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Axogen sits between Apeel Technology, Inc. (39 patents, rank #8,162) and Bedford Systems Llc (39 patents, rank #8,170) - the closest US assignees by grant volume. The composite Innovation Score of 46.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 24 grants, compared with 7 in the 2015–2019 window, a +243% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Axogen Corporation's 21.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 14 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Apeel Technology

39
Apollo Tyres Glob…

39
Arisaka

39
Avicenatech

39
Backbeat Medical

39
Base Brands

39
Bear Archery

39
Bedford Systems

39
Axogen ◀

39

What this shows Axogen holds 39 patents at rank #8,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Axogen

By rank, the assignees closest to #8,166 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Axogen's primary technology class.

Axogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Axogen Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	7.7%
2018	1	2.6%
2019	3	7.7%
2020	3	7.7%
2021	7	17.9%
2022	3	7.7%
2023	4	10.3%
2024	7	17.9%
2025partial year	8	20.5%

Which technologies does Axogen Corporation patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 19

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 14

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 7

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 6

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 5

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 5

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 4

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 4

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 3

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 3

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 1

Top 14 of 14 technology areas

Grant record at a glance

Portfolio Volume 39 grants

CPC subclasses 14

Avg. claims / grant 21.4

Velocity +243%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#8,165

of 50,000 tracked assignees

Innovation Score

46.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Axogen Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Axogen Corporation ranks #8,165 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Axogen Corporation hold?

Axogen Corporation holds 39 US utility patents granted between 2017 and 2025, spanning 14 technology areas.

What is Axogen Corporation's Innovation Score?

Axogen Corporation has an Innovation Score of 46.0 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Axogen Corporation focus on?

Axogen Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 19 patents. Grants appear in 14 CPC subclasses total.

Is Axogen Corporation's patent grant rate increasing or decreasing?

Axogen Corporation's recent grant velocity is +243% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Axogen Corporation's patents?

Axogen Corporation's patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Axogen Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Axogen's 39 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Axogen ranks #8,165 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.